Vicore Pharma Holding AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	7.74	109.35	-	-	-	-	Upgrade
Revenue Growth (YoY)	-92.57%	-	-	-	-	-	Upgrade
Gross Profit	7.74	109.35	-	-	-	-	Upgrade
Selling, General & Admin	56.06	50.44	44.6	37.53	21.61	24.99	Upgrade
Research & Development	309.2	249.26	276.29	249.97	271.81	142.02	Upgrade
Operating Expenses	365.26	299.71	320.89	287.49	293.42	167.01	Upgrade
Operating Income	-357.52	-190.36	-320.89	-287.49	-293.42	-167.01	Upgrade
Interest Expense	-40.91	-0.01	-0	-0.01	-0.01	-0.01	Upgrade
Interest & Investment Income	22.63	21.08	10.54	0.91	0.65	0.82	Upgrade
Currency Exchange Gain (Loss)	4.81	0.4	-0.62	-1.75	-1.83	-0.07	Upgrade
EBT Excluding Unusual Items	-370.99	-168.89	-310.97	-288.34	-294.61	-166.27	Upgrade
Gain (Loss) on Sale of Investments	-	-	-0.36	-0.47	-2.12	1.41	Upgrade
Other Unusual Items	-	-	-	-	-	17.54	Upgrade
Pretax Income	-370.99	-168.89	-311.33	-288.81	-296.74	-147.32	Upgrade
Income Tax Expense	-0.06	-0.26	-0.38	-0.38	-0.25	-0.45	Upgrade
Net Income	-370.92	-168.63	-310.94	-288.42	-296.48	-146.86	Upgrade
Net Income to Common	-370.92	-168.63	-310.94	-288.42	-296.48	-146.86	Upgrade
Shares Outstanding (Basic)	198	137	97	72	70	54	Upgrade
Shares Outstanding (Diluted)	198	137	97	72	70	54	Upgrade
Shares Change (YoY)	78.48%	41.72%	33.71%	3.64%	28.44%	26.04%	Upgrade
EPS (Basic)	-1.87	-1.23	-3.22	-3.99	-4.25	-2.71	Upgrade
EPS (Diluted)	-1.87	-1.23	-3.22	-3.99	-4.25	-2.71	Upgrade
Free Cash Flow	-331.04	-164.95	-249.58	-299.92	-265.17	-119.94	Upgrade
Free Cash Flow Per Share	-1.67	-1.21	-2.58	-4.15	-3.81	-2.21	Upgrade
Gross Margin	100.00%	100.00%	-	-	-	-	Upgrade
Operating Margin	-4618.46%	-174.09%	-	-	-	-	Upgrade
Profit Margin	-4791.65%	-154.22%	-	-	-	-	Upgrade
Free Cash Flow Margin	-4276.40%	-150.85%	-	-	-	-	Upgrade
EBITDA	-355.83	-188.12	-317.47	-283.88	-290.06	-163.65	Upgrade
EBITDA Margin	-	-172.04%	-	-	-	-	Upgrade
D&A For EBITDA	1.69	2.24	3.42	3.61	3.36	3.36	Upgrade
EBIT	-357.52	-190.36	-320.89	-287.49	-293.42	-167.01	Upgrade
EBIT Margin	-	-174.09%	-	-	-	-	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.